Diagnosing the decline in pharmaceutical R&D efficiency2012 · 1.3k citations
What are hit papers?
Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if any of the following hold:
it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the
threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.
Countries citing papers authored by Brian Warrington
Since Specialization
Citations
This map shows the geographic impact of Brian Warrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Warrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Warrington more than expected).
Fields of papers citing papers by Brian Warrington
This network shows the impact of papers produced by Brian Warrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Warrington. The network helps show where Brian Warrington may publish in the future.
Co-authors
The 1 scholars most cited alongside Brian Warrington, linked wherever they
have co-authored with each other. Click a name or a connecting line to browse the papers
they share.
Border = papers with Brian WarringtonLine = papers co-authored togetherBrian Warrington links everyone, so they are left out of the graph.
All Works
3 of 3 papers shown
#
Work
1
Diagnosing the decline in pharmaceutical R&D efficiency
Brian Warrington is a scholar working on Computational Theory and Mathematics, Public Health, Environmental and Occupational Health, Economics and Econometrics, Demography and Infectious Diseases, having authored 3 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (1 paper), Computational Drug Discovery Methods (1 paper), Biotechnology and Related Fields (1 paper) and Island Studies and Pacific Affairs (1 paper). The work is most often cited by research in Computational Theory and Mathematics (379 citations), Pharmacology (89 citations), Economics and Econometrics (238 citations), Biophysics (46 citations) and Management of Technology and Innovation (53 citations). Brian Warrington has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Jack W. Scannell. Their work appears in journals such as Management Decision, Nature Reviews Drug Discovery and OAR@UM (University of Malta).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.